Impact of Anemia Management on Bleeding Outcomes in Anticoagulated Patients: A Retrospective Cohort Analysis.

Clin Hematol Int · 2025 · PMC12121077 · PMID 40443840

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The bleeding rate for rivaroxaban was also significantly higher than for apixaban (OR=2.7, 95% CI:1.2–6.1, p=0.014), but the difference between rivaroxaban and warfarin did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.